PATENT CLAIM ANALYSIS

Application Number: 16134417
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "234100"]

Abstract:
Disclosed is the use of fluorinated cyclic dinucleotides and pharmaceutically acceptable salts thereof as an adjuvant for the preparation of an oral vaccine. Further disclosed is the use of fluorinated cyclic dinucleotides and pharmaceutically acceptable salts thereof for enhancing the immune response to an orally administered vaccine.

Claim (Index 33):
The oral vaccine according to  claim 31 , wherein the composition comprising  H. pylori  antigen comprises  H. pylori  cell free extract or one or more  H. pylori  specific peptides and/or proteins.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.68966
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15038229', '11669006', '13748412', '12092747', '15630741']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.619674804328965
- 35 USC 102 Novelty (BERT): 0.5739310251504042
- Combined Prediction Score: 0.615100426411109
- Mean Citation Score: 311.59269
- Max Citation Score: 522.6394700000002
- Similarity Product: 327.01003207779894

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test